Medicine
Volume 37, Issue 8 , Pages 403-406, August 2009

Cushing's syndrome

Alia Munir MBBCh is The Society for Endocrinology and Clinical Endocrinology Trust Research Fellow, University of Sheffield, UK. Competing interests: none declared

John Newell-Price MA PhD FRCP is Reader in Endocrinology and Consultant Endocrinologist at the University of Sheffield, and Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Trust, UK. Competing interests: none declared

Abstract 

Endogenous Cushing’s syndrome results from prolonged, excessive and inappropriate levels of circulating cortisol. Cushing’s syndrome should be considered in patients with unusual features for age, patients with multiple and progressive features, children with decreasing height percentile and increasing weight, and in patients with adrenal adenoma found incidentally. Endogenous Cushing’s syndrome is more common in women than men. Adrenocorticotrophic hormone (ACTH)-dependent causes account for about 80% of cases. Of ACTH-dependent cases, 80% result from pituitary adenomas (Cushing’s disease) and the remainder from ectopic ACTH secretion. Non-ACTH-dependent Cushing’s syndrome is caused by benign adrenal adenomas in 60% and carcinomas in 40%. Specialist assessment and treatment warrants referral to major centres. For diagnosis the most discriminating features are thin skin, easy bruising and proximal myopathy. Biochemical diagnosis is by a combination of low-dose dexamethasone suppression tests, assessment of loss of circadian rhythm and urinary free cortisol. When differentiating pituitary and non-pituitary sources of ACTH, reliance should be placed on biochemical evaluation. Medical therapy is often used preoperatively to lower plasma cortisol, postoperatively to control levels in patients not cured, and following radiotherapy. Transsphenoidal surgery is the treatment of choice for Cushing’s disease; laparoscopic bilateral adrenalectomy is increasingly used in refractory cases.

Keywords: adrenal, adrenocorticotrophic hormone, cortisol, Cushing's, dexamethasone, ectopic, pituitary

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1357-3039(09)00155-8

doi:10.1016/j.mpmed.2009.05.013

Medicine
Volume 37, Issue 8 , Pages 403-406, August 2009